234 related articles for article (PubMed ID: 33631356)
1. Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol.
Harris RA; Mandell DS; Kampman KM; Bao Y; Campbell K; Cidav Z; Coviello DM; French R; Livesey C; Lowenstein M; Lynch KG; McKay JR; Oslin DW; Wolk CB; Bogner HR
Contemp Clin Trials; 2021 Apr; 103():106325. PubMed ID: 33631356
[TBL] [Abstract][Full Text] [Related]
2. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
[TBL] [Abstract][Full Text] [Related]
3. A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trial.
DeBar LL; Bushey MA; Kroenke K; Bobb JF; Schoenbaum M; Thompson EE; Justice M; Zatzick D; Hamilton LK; McMullen CK; Hallgren KA; Benes LL; Forman DP; Caldeiro RM; Brown RP; Campbell NL; Anderson ML; Son S; Haggstrom DA; Whiteside L; Schleyer TKL; Bradley KA
Contemp Clin Trials; 2023 Apr; 127():107124. PubMed ID: 36804450
[TBL] [Abstract][Full Text] [Related]
4. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
[TBL] [Abstract][Full Text] [Related]
5. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.
Ober AJ; Murray-Krezan C; Page K; Friedmann PD; Chan Osilla K; Ryzewicz S; Huerta S; Mazer MW; Leamon I; Messineo G; Watkins KE; Nuckols T; Danovitch I
Addict Sci Clin Pract; 2022 Jul; 17(1):39. PubMed ID: 35902888
[TBL] [Abstract][Full Text] [Related]
6. Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.
Meredith LS; Komaromy MS; Cefalu M; Murray-Krezan C; Page K; Osilla KC; Dopp AR; Leamon I; Tarhuni L; Hindmarch G; Jacobsohn V; Watkins KE;
Contemp Clin Trials; 2021 May; 104():106354. PubMed ID: 33713840
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model.
Brackett CD; Duncan M; Wagner JF; Fineberg L; Kraft S
Subst Abus; 2022; 43(1):240-244. PubMed ID: 34086531
[No Abstract] [Full Text] [Related]
8. Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders.
Osilla KC; Dopp AR; Watkins KE; Ceballos V; Hurley B; Meredith LS; Leamon I; Jacobsohn V; Komaromy M
Addict Sci Clin Pract; 2022 Apr; 17(1):25. PubMed ID: 35395811
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
Wu LT; John WS; Ghitza UE; Wahle A; Matthews AG; Lewis M; Hart B; Hubbard Z; Bowlby LA; Greenblatt LH; Mannelli P;
Addiction; 2021 Jul; 116(7):1805-1816. PubMed ID: 33428284
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians.
Hooker SA; Crain AL; LaFrance AB; Kane S; Fokuo JK; Bart G; Rossom RC
Addict Sci Clin Pract; 2023 Feb; 18(1):10. PubMed ID: 36774521
[TBL] [Abstract][Full Text] [Related]
11. Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder.
Pals H; Bratberg J
J Am Pharm Assoc (2003); 2022; 62(4):1422-1429. PubMed ID: 35365405
[TBL] [Abstract][Full Text] [Related]
12. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.
Forray A; Mele A; Byatt N; Londono Tobon A; Gilstad-Hayden K; Hunkle K; Hong S; Lipkind H; Fiellin DA; Callaghan K; Yonkers KA
PLoS One; 2022; 17(1):e0261751. PubMed ID: 35025898
[TBL] [Abstract][Full Text] [Related]
13. Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods.
Liebschutz JM; Subramaniam GA; Stone R; Appleton N; Gelberg L; Lovejoy TI; Bunting AM; Cleland CM; Lasser KE; Beers D; Abrams C; McCormack J; Potter GE; Case A; Revoredo L; Jelstrom EM; Kline MM; Wu LT; McNeely J
Addict Sci Clin Pract; 2023 Nov; 18(1):70. PubMed ID: 37980494
[TBL] [Abstract][Full Text] [Related]
14. Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care.
Rossom RC; Crain AL; O'Connor PJ; Wright E; Haller IV; Hooker SA; Sperl-Hillen JM; Olson A; Romagnoli K; Solberg L; Dehmer SP; Haapala J; Borgert-Spaniol C; Tusing L; Muegge J; Allen C; Ekstrom H; Huntley K; McCormack J; Bart G
Contemp Clin Trials; 2023 Jan; 124():107012. PubMed ID: 36402275
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
Rhee TG; Rosenheck RA
Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
[TBL] [Abstract][Full Text] [Related]
16. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.
McNeely J; Troxel AB; Kunins HV; Shelley D; Lee JD; Walley A; Weinstein ZM; Billings J; Davis NJ; Marcello RK; Schackman BR; Barron C; Bergmann L
Addict Sci Clin Pract; 2019 Feb; 14(1):5. PubMed ID: 30777122
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder.
Rossom RC; Sperl-Hillen JM; O'Connor PJ; Crain AL; Nightingale L; Pylkas A; Huntley KV; Bart G
Addict Sci Clin Pract; 2021 Jun; 16(1):37. PubMed ID: 34130758
[TBL] [Abstract][Full Text] [Related]
18. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
Wartko PD; Bobb JF; Boudreau DM; Matthews AG; McCormack J; Lee AK; Qiu H; Yu O; Hyun N; Idu AE; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Labelle CT; Zare-Mehrjerdi M; Stotts AL; Braciszewski JM; Murphy MT; Dryden D; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Phillips RC; Shea M; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Lapham GT; Addis M; Bradley KA; ; Ghiroli MM; Hamilton LK; Hu Y; LaHue JS; Loree AM; Murphy SM; Northrup TF; Shmueli-Blumberg D; Silva AJ; Weinstein ZM; Wong MT; Burganowski RP
JAMA Intern Med; 2023 Dec; 183(12):1343-1354. PubMed ID: 37902748
[TBL] [Abstract][Full Text] [Related]
19. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.
Banta-Green CJ; Owens MD; Williams JR; Sears JM; Floyd AS; Williams-Gilbert W; Kingston S
Addict Sci Clin Pract; 2022 Jul; 17(1):34. PubMed ID: 35799210
[TBL] [Abstract][Full Text] [Related]
20. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
